1,498 results on '"Rosendaal, F"'
Search Results
152. Risk of venous thrombosis associated with coagulation factor VIII levels and the interrelation of other procoagulant and environmental risk factors: PB 3.55–2
153. Aspirin intake AM or PM?: effect on platelet reactivity in the morning: PB 2.74.5
154. The incidence of recurrent venous thrombosis associated with different clinical risk profiles: PB 2.71–2
155. Risk of myocardial infarction and ischaemic stroke and the impact of hypercoagulability - the RATIO case control study: PB 1.63–3
156. Levels of the ADAMTS13 metalloprotease and risk of myocardial infarction: review of the literature and meta-analysis: PB 1.33–6
157. Replication and meta-analysis of the association between F11 genetic variants and the risk of incident venous thrombosis by statin use: PA 4.18–3
158. Prediction of risk of venous thrombosis after cast immobilization of the lower extremity: PA 3.19–1
159. The contribution of immobility risk factors to the risk of venous thrombosis in the older population: PA 3.19–6
160. Red cell distribution width and blood monocytes are associated with an increased risk of venous thrombosis: OC 63.6
161. Current statin use and its association with recurrent venous thrombosis: OC 63.1
162. Arthroscopy of the knee and risk of venous thrombosis: results from the MEGA study: OC 59.3
163. Optimal risk estimation for DVT requires measurement of coagulation protein concentrations: OC 59.4
164. Statin use and bleeding complications during treatment with vitamin K antagonists: a cohort study in 8188 patients with atrial fibrillation: OC 42.4
165. Genetic variants in cell adhesion molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor: OC 47.2
166. The risk of venous thrombosis varies in different ethnic groups: OC 30.3
167. Candidate genetic polymorphisms and their associations with incident and recurrent venous thrombosis: OC 30.5
168. Sex difference in incidence of first venous thrombosis: a higher risk in men than in women: OC 30.6
169. Recurrent venous thrombosis in premenopausal women: effect of hormonal contraceptive use: OC 12.6
170. The risk of venous thrombosis in patients with malignancy is largely mediated through levels of factor VIII and von Willebrand factor: OC 04.2
171. June Editorial
172. May Editorial
173. Genetic variants associated with protein C levels
174. Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups
175. April Editorial
176. Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsφ: reply to a rebuttal
177. Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal
178. Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women
179. Risk of venous thrombosis in patients with major illnesses: results from the MEGA study
180. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy
181. New editorial crew
182. Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands
183. Platelet reactivity is not associated with recurrent cardiovascular events in men with a history of myocardial infarction: a cohort study
184. Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels
185. Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients
186. High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case–control study
187. Etiology of venous thrombosis: the need for small original studies
188. Cigarette smoking and the risk of venous thromboembolism: The Tromsφ Study
189. Sex hormone-binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives
190. The relationship between body mass index, activated protein C resistance and risk of venous thrombosis
191. Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsφ
192. The effect of time between venipuncture, processing and freezing on the measurement of coagulation factor levels
193. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
194. Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study
195. Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands
196. Pneumonia and risk of venous thrombosis: results from the MEGA study
197. HEART RATE VARIABILITY AND CAROTID INTIMA-MEDIA THICKNESS IN OVERWEIGHT OR OBESE ADULTS: THE NEO STUDY: 362 accepted poster
198. FASTING AND POSTPRANDIAL SERUM LIPIDS AND PULMONARY FUNCTION IN PERSONS WITH OVERWEIGHT OR OBESITY: THE NEO STUDY: 360 accepted poster
199. HEART RATE VARIABILITY, POSTPRANDIAL RESPONSES OF GLUCOSE AND INSULIN AND BETA-CELL FUNCTION: THE NEO STUDY: 363 accepted poster
200. BODY MASS INDEX, WAIST CIRCUMFERENCE AND HEART RATE VARIABILITY IN ADULTS WITH OVERWEIGHT OR OBESITY: THE NEO STUDY: 350 accepted poster
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.